(5S)-7-cyclohexyloxy-5-[(2-methylpropan-2-yl)oxycarbonylamino]-4,7-dioxo-2-propan-2-ylheptanoic acid
C21H35NO7 — CID 10525791
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5S)-7-cyclohexyloxy-5-[(2-methylpropan-2-yl)oxycarbonylamino]-4,7-dioxo-2-propan-2-ylheptanoic acid
(5S)-7-cyclohexyloxy-5-[(2-methylpropan-2-yl)oxycarbonylamino]-4,7-dioxo-2-propan-2-ylheptanoic acid (PubChem CID 10525791) has the molecular formula C21H35NO7 and a molecular weight of 413.51 g/mol. Its IUPAC name is (5S)-7-cyclohexyloxy-5-[(2-methylpropan-2-yl)oxycarbonylamino]-4,7-dioxo-2-propan-2-ylheptanoic acid.
Molecular Properties
| Compound Name | (5S)-7-cyclohexyloxy-5-[(2-methylpropan-2-yl)oxycarbonylamino]-4,7-dioxo-2-propan-2-ylheptanoic acid |
|---|---|
| PubChem CID | 10525791 |
| Molecular Formula | C21H35NO7 |
| Molecular Weight | 413.51 g/mol |
| Exact Mass | 413.24 |
| IUPAC Name | (5S)-7-cyclohexyloxy-5-[(2-methylpropan-2-yl)oxycarbonylamino]-4,7-dioxo-2-propan-2-ylheptanoic acid |
| SMILES | CC(C)C(CC(=O)[C@H](CC(=O)OC1CCCCC1)NC(=O)OC(C)(C)C)C(=O)O |
| InChI | InChI=1S/C21H35NO7/c1-13(2)15(19(25)26)11-17(23)16(22-20(27)29-21(3,4)5)12-18(24)28-14-9-7-6-8-10-14/h13-16H,6-12H2,1-5H3,(H,22,27)(H,25,26)/t15?,16-/m0/s1 |
| InChIKey | MLDGZGOYMZTHMX-LYKKTTPLSA-N |
| XLogP | 3.46 |
| TPSA | 119.00 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 413.51 |
| LogP ≤ 5 | 3.46 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 10525791 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.